Akebia Therapeutics, Inc. (AKBA)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 31, 16:00
1.605
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.61 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 24.90 |
| Plus Therapeutics, Inc. | 0.5123 |
| Ironwood Pharmaceuticals, Inc. | 3.37 |
| Pyxis Oncology, Inc. | 1.15 |
| Theravance Biopharma, Inc. | 18.71 |
Price Related Metrics
| PS Ratio | 1.799 |
| Price to Book Value | 10.27 |
| Price to Free Cash Flow | 12.58 |
| Earnings Yield | -4.73% |
| Market Cap | 427.24M |
| Operating PE Ratio | 22.81 |